Buy Adverum Biotechnologies Stock | ADVM Stock Price & Latest News | Public.com

Adverum Biotechnologies

$0.00 (0.00%)Today

About ADVM

Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitry...Read more

Community

People who own or watch this stock

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1.4

Price Targets

What analysts think this stock will be worth

$20.82
current
$23.88
average

Events

List of events that could affect this stock.

28May

Earnings data Q1 2020

06Aug

Earnings data Q2 2020

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-0.1
-0.21
-0.31
Q4 2019
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$0.29

Actual EPS
Q3 2020

Stats

Market Cap$1,67B
Volume20,85k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$26.98
1 Year Low$4.96
Open$21.00
High$21.23
Low$20.50

Buy any stock with any amount of money.

Download the App
Download the app